Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gade, J; Qvortrup, K; Andersen, CB; Thorsen, S; Svendsen, UG; Olsen, PS
   Bronchial arterial devascularization. An experimental study in pigs
   SCANDINAVIAN CARDIOVASCULAR JOURNAL
   
   J. Gade et al., "Bronchial arterial devascularization. An experimental study in pigs", SC CARDIOVA, 35(3), 2001, pp. 212-220
2. Lind, B; Koefoed, P; Thorsen, S
   Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain
   BRITISH JOURNAL OF HAEMATOLOGY
   
   B. Lind et al., "Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain", BR J HAEM, 113(3), 2001, pp. 642-648
3. Philips, M; Johnsen, H; Thorsen, S
   Characterization of a complex between active plasminogen activator inhibitor-1 and N-terminal fragments of vitronectin from human placenta
   FIBRINOLYSIS & PROTEOLYSIS
   
   M. Philips et al., "Characterization of a complex between active plasminogen activator inhibitor-1 and N-terminal fragments of vitronectin from human placenta", FIBRINOL PR, 14(1), 2000, pp. 22-34
4. Bangert, K; Thorsen, S
   Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis
   THROMBOSIS AND HAEMOSTASIS
   
   K. Bangert e S. Thorsen, "Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis", THROMB HAEM, 84(2), 2000, pp. 299-306
5. Ny, T; Thorsen, S; Wiman, B
   Per Wallen - Obituary
   FIBRINOLYSIS & PROTEOLYSIS
   
   T. Ny et al., "Per Wallen - Obituary", FIBRINOL PR, 13(4-5), 1999, pp. 216-216
6. Frikke-Schmidt, R; Arlien-Soborg, P; Thorsen, S; Jensen, HK; Vorstrup, S
   LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are
   EUROPEAN JOURNAL OF NEUROLOGY
   
   R. Frikke-Schmidt et al., "LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are", EUR J NEUR, 6(6), 1999, pp. 691-696
7. Lind, B; Thorsen, S
   A novel missense mutation in the human plasmin inhibitor (alpha(2)-antiplasmin) gene associated with a bleeding tendency
   BRITISH JOURNAL OF HAEMATOLOGY
   
   B. Lind e S. Thorsen, "A novel missense mutation in the human plasmin inhibitor (alpha(2)-antiplasmin) gene associated with a bleeding tendency", BR J HAEM, 107(2), 1999, pp. 317-322
8. TAANING E; KNUDSEN FU; THORSEN S; JONSSON V
   IMMUNIZATION AGAINST PLATELET GLYCOPROTEIN IIB-IIIA IN GLANZMANNS-THROMBASTHENIA
   European journal of haematology
   
   E. Taaning et al., "IMMUNIZATION AGAINST PLATELET GLYCOPROTEIN IIB-IIIA IN GLANZMANNS-THROMBASTHENIA", European journal of haematology, 58(5), 1997, pp. 360-361
9. LIND B; JOHNSEN AH; THORSEN S
   NATURALLY-OCCURRING ARG-1 TO HIS MUTATION IN HUMAN PROTEIN-C LEADS TOABERRANT PROPEPTIDE PROCESSING AND SECRETION OF DYSFUNCTIONAL PROTEIN-C
   Thrombosis and haemostasis
   
   B. Lind et al., "NATURALLY-OCCURRING ARG-1 TO HIS MUTATION IN HUMAN PROTEIN-C LEADS TOABERRANT PROPEPTIDE PROCESSING AND SECRETION OF DYSFUNCTIONAL PROTEIN-C", Thrombosis and haemostasis, 1997, pp. 1691-1691
10. BANGERT K; JOHNSEN AH; THORSEN S
    CHARACTERIZATION AND ASSAY OF RAT PLASMINOGEN (PG)
    Thrombosis and haemostasis
    
    K. Bangert et al., "CHARACTERIZATION AND ASSAY OF RAT PLASMINOGEN (PG)", Thrombosis and haemostasis, 1997, pp. 2291-2291
11. GRIP L; FRISON L; WALLENTIN L; DELLBORG M; GRANDE P; HALINEN M; HELD P; MYHRE E; RYDEN L; SWAHN E; SWEDBERG K; THYGESEN K; SLEIGHT P; WILHELMSEN L; NASLUND U; GUNDERSEN T; FISCHERHANSEN J; LEHTO S; BARRET M; NILSSON JE; TEGERNILSSON AC; THORSEN M; ANDERSEN F; LUNDSTROM M; HILDEBRAND A; DEFLONOLSSON C; FORSBY M; ISBERG P; LARSSON C; NORGAARD B; RASMUSSEN S; VIDEBAEK J; KLARLUND K; LANDORPH A; NIELSEN T; AGNER E; HOJGAARD MV; HELQVIST S; RASMUSSEN SL; EGSTRUP K; MYGIND L; HANSEN JF; SAJADIEH A; GILL S; HAGHFELT T; MARKENVARD J; THOMASSEN A; JENSEN N; PETERSEN J; JENSEN G; FISCHER T; SIPILA R; KIILAVUORI K; HAMALAINEN L; NURMINEN J; MELIN J; KOSKELA E; HURME H; VAUHONEN I; HONKANEN T; UTRIANEN S; HAMALAINEN T; LILJA M; UKKOLVA O; KIVELA H; SODERSTROM S; POHJOLASINTONEN S; HUSSI E; LARSEN A; FALANG JE; SCHARTUMHANSEN H; PAULSEN A; OMLAND T; HOLM T; EDVARDSEN T; THYBO NK; HAEREM J; KAPELRUD H; WAAGE K; ROSSEBO B; HAFSOY K; HAMMARSTROM E; ASTROM L; HALL E; WETTERVIK C; FORSBERG SA; TYGESEN H; FREDRIKSSON B; EKDAHL S; KIHLSTROM K; MAGNUSSON JO; STJERNA A; MARU F; NILSSON H; AKRAWI S; SAETRE H; AHLMARK G; AHLBERG G; LINDE B; HAGSTROM L; GUSTAFSSON G; GUSTAVSSON PE; LARSSON AC; ANDERSEN K; RUTER G; KIERKEGAARD A; HARDHAMMAR P; KARLSSON JE; SVENSSON O; LANDGREN F; HOLMBERG B; RYDEN S; WEINER L; DANIELEWICZ M; MALMROS B; NICOL P; JANZON M; OHLIN H; HANSEN O; TINGBERG E; NYMAN I; FJELSTAD B; AHLSTROM P; HEDBACK B; PERK J; SVENNBERG L; ELLSTROM J; BOMAN K; REMMETS J; KRISTENSSON BE; LINDER R; HULTING J; HOIJER J; MOLLER BH; LYCKSELL M; WAHLIN M; SANDSTEDT L; REDFORS A; BORRETZEN J; OSTBERG G; JOHANSSON B; MORNER S; LINDAHL B; OLDGREN J; JONSSON J; NEMECZE K; THORSEN S; JOHANSSON PA; SINNERSTAD B; LARSSON LE; BAND S; MARSELL R
    A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY
    European heart journal
    
    L. Grip et al., "A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY", European heart journal, 18(9), 1997, pp. 1416-1425
12. BLOMBACK M; DYBKAER R; JORGENSEN K; OLESEN H; THORSEN S
    PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES .5. PROPERTIES AND UNITS IN THROMBOSIS AND HEMOSTASIS
    Pure and applied chemistry
    
    M. Blomback et al., "PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES .5. PROPERTIES AND UNITS IN THROMBOSIS AND HEMOSTASIS", Pure and applied chemistry, 69(5), 1997, pp. 1043-1079
13. LIND B; JOHNSEN AH; THORSEN S
    NATURALLY-OCCURRING ARG(-1) TO HIS MUTATION IN HUMAN PROTEIN-C LEADS TO ABERRANT PROPEPTIDE PROCESSING AND SECRETION OF DYSFUNCTIONAL PROTEIN-C
    Blood
    
    B. Lind et al., "NATURALLY-OCCURRING ARG(-1) TO HIS MUTATION IN HUMAN PROTEIN-C LEADS TO ABERRANT PROPEPTIDE PROCESSING AND SECRETION OF DYSFUNCTIONAL PROTEIN-C", Blood, 89(8), 1997, pp. 2807-2816
14. ANDERSEN BD; LIND B; PHILIPS M; HANSEN AB; INGERSLEV J; THORSEN S
    2 MUTATIONS IN EXON-XII OF THE PROTEIN S-ALPHA GENE IN 4 THROMBOPHILIC FAMILIES RESULTING IN PREMATURE STOP CODONS AND DEPRESSED LEVELS OF MUTATED MESSENGER-RNA
    Thrombosis and haemostasis
    
    B.D. Andersen et al., "2 MUTATIONS IN EXON-XII OF THE PROTEIN S-ALPHA GENE IN 4 THROMBOPHILIC FAMILIES RESULTING IN PREMATURE STOP CODONS AND DEPRESSED LEVELS OF MUTATED MESSENGER-RNA", Thrombosis and haemostasis, 76(2), 1996, pp. 143-150
15. WALLENTIN L; OHLSSON J; SWAHN E; KARLSSON E; LUNDIN L; LANDGREN F; SAETRE H; ADREN B; ENGHOFF E; LUNDSTROM T; HJALMARSSON A; NORDLANDER R; ANDREN B; BLOMSTRAND P; VENGE P; SIEGBAHN A; ALMROTH G; JOHANSSON C; NORMARK A; WIKLUND K; LOGANDER E; LINDSTROM G; SVENSSON E; UNDELAND S; NEIGER K; PERERS G; IRVING P; ANDERSSON I; HAMMARSTROM E; BASTANI H; ENG E; LUNDIN P; REHNQVIST N; AMBRANT B; OBLACK P; HOLMSTRAND M; EKDAHL S; NYMAN I; PANTZAR Y; AHLBERG G; HAGSTROM L; SUNDQVIST C; PIHL E; GUSTAFSSON G; LARSSON L; GUSTAVSSON PE; LOFMARK R; LUNDQVIST IB; LUNDQVIST L; ANGMAN K; KARLSSON JE; SVENSSON O; MALMBERG C; HOLMBERG B; RYDEN S; BJURLING E; ABJORN C; WAHLFORS AL; MALMROS B; NICOL P; ROWA M; NIELSEN N; SAFSTROM K; FRISELL JE; HEDMAN A; SANDSTOM M; AHLSTROM P; ROSENQVIST U; RYDEN BO; GUSTAVSSON SB; ALMEN I; FJELSTAD B; ARONSON D; OSTBERG S; FALK SA; FRIDEN J; NILSSON O; RONNHAGEN K; ABOUZEID L; HEDBACK B; PERK J; OSSIANSSONPETTERSSON L; ELLSTROM J; BRODERSSON H; VONHOLST M; KJELLINWIBERG A; HULTING J; HOJIER J; AMANULLAH A; SAMAD B; STEINBRUCK I; EKBLOM M; TOSS H; LINDAHL B; ALSJO G; SINNERSTAD B; LARSSON LE; NILSSON G; AGERT G; WIBERG S; PIHLSTROM B; JOHANSSON PA; LIND O; THORSEN S; EKBERG K
    LOW-MOLECULAR-WEIGHT HEPARIN DURING INSTABILITY IN CORONARY-ARTERY DISEASE
    Lancet
    
    L. Wallentin et al., "LOW-MOLECULAR-WEIGHT HEPARIN DURING INSTABILITY IN CORONARY-ARTERY DISEASE", Lancet, 347(9001), 1996, pp. 561-568
16. BLOMBACK M; DYBKAER R; JORGENSEN K; OLESEN H; THORSEN S
    PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES .5. PROPERTIES AND UNITS IN THROMBOSIS AND HEMOSTASIS - ISTH-IUPAC-IFCC RECOMMENDATIONS 1995
    Clinica chimica acta
    
    M. Blomback et al., "PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES .5. PROPERTIES AND UNITS IN THROMBOSIS AND HEMOSTASIS - ISTH-IUPAC-IFCC RECOMMENDATIONS 1995", Clinica chimica acta, 245(2), 1996, pp. 23-28
17. FRIKKESCHMIDT R; TYBJAERGHANSEN A; VORSTRUP S; ARLIENSOBORG P; PHILIPS M; THORSEN S
    GENETIC AND BIOCHEMICAL RISK-FACTORS FOR ISCHEMIC CEREBROVASCULAR-DISEASE OF THE YOUNG
    Circulation
    
    R. Frikkeschmidt et al., "GENETIC AND BIOCHEMICAL RISK-FACTORS FOR ISCHEMIC CEREBROVASCULAR-DISEASE OF THE YOUNG", Circulation, 94(8), 1996, pp. 2275-2275
18. BLOMBACK M; DYBKAER R; JORGENSEN K; OLESEN H; THORSEN S
    PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES .5. PROPERTIES AND UNITS IN THROMBOSIS AND HEMOSTASIS
    European journal of clinical chemistry and clinical biochemistry
    
    M. Blomback et al., "PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES .5. PROPERTIES AND UNITS IN THROMBOSIS AND HEMOSTASIS", European journal of clinical chemistry and clinical biochemistry, 33(9), 1995, pp. 637-660
19. SKOV RL; KLARLUND M; THORSEN S
    FATAL ENDOCARDITIS DUE TO AEROCOCCUS-URINAE
    Diagnostic microbiology and infectious disease
    
    R.L. Skov et al., "FATAL ENDOCARDITIS DUE TO AEROCOCCUS-URINAE", Diagnostic microbiology and infectious disease, 21(4), 1995, pp. 219-221
20. LIND B; SCHWARTZ M; THORSEN S
    6 DIFFERENT POINT MUTATIONS IN 7 DANISH FAMILIES WITH SYMPTOMATIC PROTEIN-C DEFICIENCY
    Thrombosis and haemostasis
    
    B. Lind et al., "6 DIFFERENT POINT MUTATIONS IN 7 DANISH FAMILIES WITH SYMPTOMATIC PROTEIN-C DEFICIENCY", Thrombosis and haemostasis, 73(2), 1995, pp. 186-193
21. LIJNEN HR; BACHMANN F; COLLEN D; ELLIS V; PANNEKOEK H; RIJKEN DC; THORSEN S
    MECHANISMS OF PLASMINOGEN ACTIVATION
    Journal of internal medicine
    
    H.R. Lijnen et al., "MECHANISMS OF PLASMINOGEN ACTIVATION", Journal of internal medicine, 236(4), 1994, pp. 415-424
22. BLOMBACK M; ABILDGAARD U; VANDENBESSELAAR AMHP; CLEMENTSON KJ; DAHLBACK B; EXNER T; FRANCIS CW; GAFFNEY P; GRALNICK H; HOYER LW; JOHNSON GJ; KASPER C; LANE D; LIJNEN HR; LUSHER JM; MANNUCCI PM; POLLER L; RAPAPORT SI; SAITO H; STOCKER K; THOMAS D; BARROWCLIFFE TW; HEMKER C; THORSEN S; ARONSON D; MANN KG; MEYER D; ROBERTS HR; DYBKAER R; JORGENSEN K; OLESEN H
    NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY
    Thrombosis and haemostasis
    
    M. Blomback et al., "NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY", Thrombosis and haemostasis, 71(3), 1994, pp. 375-394
23. BAUER R; HANSEN SL; JONES G; SUENSON E; THORSEN S; OGENDAL L
    FIBRIN STRUCTURES DURING TISSUE-TYPE PLASMINOGEN ACTIVATOR-MEDIATED FIBRINOLYSIS STUDIED BY LASER-LIGHT SCATTERING - RELATION TO FIBRIN ENHANCEMENT OF PLASMINOGEN ACTIVATION
    European biophysics journal
    
    R. Bauer et al., "FIBRIN STRUCTURES DURING TISSUE-TYPE PLASMINOGEN ACTIVATOR-MEDIATED FIBRINOLYSIS STUDIED BY LASER-LIGHT SCATTERING - RELATION TO FIBRIN ENHANCEMENT OF PLASMINOGEN ACTIVATION", European biophysics journal, 23(4), 1994, pp. 239-252
24. BAUER R; HANSEN SL; JONES G; SUENSON E; THORSEN S; OGENDAL L
    FIBRIN STRUCTURES DURING TISSUE-TYPE PLASMINOGEN ACTIVATOR-MEDIATED FIBRINOLYSIS STUDIED BY LASER-LIGHT SCATTERING - RELATION TO FIBRIN ENHANCEMENT OF PLASMINOGEN ACTIVATION
    European biophysics journal
    
    R. Bauer et al., "FIBRIN STRUCTURES DURING TISSUE-TYPE PLASMINOGEN ACTIVATOR-MEDIATED FIBRINOLYSIS STUDIED BY LASER-LIGHT SCATTERING - RELATION TO FIBRIN ENHANCEMENT OF PLASMINOGEN ACTIVATION", European biophysics journal, 23(4), 1994, pp. 239-252
25. DONNER M; KRISTOFFERSSON AC; BERNTORP E; SCHEIBEL E; THORSEN S; DAHLBACK B; NILSSON IM; HOLMBERG L
    2 NEW CANDIDATE MUTATIONS IN TYPE-IIA VON-WILLEBRANDS DISEASE (ARG(834)-]GLY, GLY(846)-]ARG) AND ONE POLYMORPHISM (TYR(821)-]CYS) IN THE A2REGION OF THE VON-WILLEBRAND-FACTOR
    European journal of haematology
    
    M. Donner et al., "2 NEW CANDIDATE MUTATIONS IN TYPE-IIA VON-WILLEBRANDS DISEASE (ARG(834)-]GLY, GLY(846)-]ARG) AND ONE POLYMORPHISM (TYR(821)-]CYS) IN THE A2REGION OF THE VON-WILLEBRAND-FACTOR", European journal of haematology, 51(1), 1993, pp. 38-44
26. LIND B; VANSOLINGE W; SCHWARTZ M; THORSEN S
    SPLICE-SITE MUTATION IN THE HUMAN PROTEIN-C GENE ASSOCIATED WITH VENOUS THROMBOSIS - DEMONSTRATION OF EXON SKIPPING BY ILLEGITIMATE TRANSCRIPT ANALYSIS
    Thrombosis and haemostasis
    
    B. Lind et al., "SPLICE-SITE MUTATION IN THE HUMAN PROTEIN-C GENE ASSOCIATED WITH VENOUS THROMBOSIS - DEMONSTRATION OF EXON SKIPPING BY ILLEGITIMATE TRANSCRIPT ANALYSIS", Thrombosis and haemostasis, 69(6), 1993, pp. 999-999
27. LIND B; SCHWARTZ M; THORSEN S
    6 DIFFERENT MISSENSE MUTATIONS IN 7 DANISH FAMILIES WITH SYMPTOMATIC PROTEIN-C DEFICIENCY
    Thrombosis and haemostasis
    
    B. Lind et al., "6 DIFFERENT MISSENSE MUTATIONS IN 7 DANISH FAMILIES WITH SYMPTOMATIC PROTEIN-C DEFICIENCY", Thrombosis and haemostasis, 69(6), 1993, pp. 1254-1254
28. BANGERT K; JOHNSEN AH; CHRISTENSEN U; THORSEN S
    DIFFERENT N-TERMINAL FORMS OF ALPHA-2-PLASMIN INHIBITOR IN HUMAN PLASMA
    Biochemical journal
    
    K. Bangert et al., "DIFFERENT N-TERMINAL FORMS OF ALPHA-2-PLASMIN INHIBITOR IN HUMAN PLASMA", Biochemical journal, 291, 1993, pp. 623-625
29. THORSEN S; RONNERASMUSSEN J; PETERSEN E; ISAGER H; SEEFELDT T; MATHIESEN L
    EXTRAINTESTINAL AMEBIASIS - CLINICAL PRESENTATION IN A NONENDEMIC SETTING
    Scandinavian journal of infectious diseases
    
    S. Thorsen et al., "EXTRAINTESTINAL AMEBIASIS - CLINICAL PRESENTATION IN A NONENDEMIC SETTING", Scandinavian journal of infectious diseases, 25(6), 1993, pp. 747-750
30. LIND B; VANSOLINGE WW; SCHWARTZ M; THORSEN S
    SPLICE-SITE MUTATION IN THE HUMAN PROTEIN-C GENE ASSOCIATED WITH VENOUS THROMBOSIS - DEMONSTRATION OF EXON SKIPPING BY ECTOPIC TRANSCRIPT ANALYSIS
    Blood
    
    B. Lind et al., "SPLICE-SITE MUTATION IN THE HUMAN PROTEIN-C GENE ASSOCIATED WITH VENOUS THROMBOSIS - DEMONSTRATION OF EXON SKIPPING BY ECTOPIC TRANSCRIPT ANALYSIS", Blood, 82(8), 1993, pp. 2423-2432
31. BAGGER PV; ANDERSEN V; BASLUND B; BECK B; HOVE H; HOIERMADSEN M; PETERSEN J; PHILIP J; SCHAADT O; SKOUBY SO; STARUP J; THORSEN S; WIIK A
    ANTICARDIOLIPIN ANTIBODIES (IGG AND IGA) IN WOMEN WITH RECURRENT FETAL LOSS CORRELATE TO CLINICAL AND SEROLOGICAL CHARACTERISTICS OF SLE
    Acta obstetricia et gynecologica Scandinavica
    
    P.V. Bagger et al., "ANTICARDIOLIPIN ANTIBODIES (IGG AND IGA) IN WOMEN WITH RECURRENT FETAL LOSS CORRELATE TO CLINICAL AND SEROLOGICAL CHARACTERISTICS OF SLE", Acta obstetricia et gynecologica Scandinavica, 72(6), 1993, pp. 465-469